Chemotherapy-induced Peripheral Neuropathy
📧 Sign up to get email alerts when something new happens for Chemotherapy-induced Peripheral Neuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: International CIPN Assessment and Validation Study
An international study is recruiting to assess and validate CIPN assessment tools and their impact on quality of life in patients with chemo…
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Safety and Efficacy Study of TAR-0520 Gel in Prevention of Taxane-induced Peripheral Neuropathy [Phase 2]
A Phase 2 study assessing TAR-0520 Gel for prevention of taxane-induced peripheral neuropathy, currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Real-World Pharmacological Treatment Pattern of Neuropathic Pain in China
A completed clinical trial update reports real-world pharmacological treatment patterns for neuropathic pain in China, including diabetic pe…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Heat and Cold Therapy for Chemotherapy-Induced Neuropathy [NA]
Completed clinical trial evaluating heat and cold therapy for chemotherapy-induced peripheral neuropathy to assess potential symptom relief …
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors [NA]
A clinical trial update announces that Yale University is recruiting for a study evaluating light therapy to treat chemotherapy-induced peri…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Helping Cancer Patients Manage Neuropathy Symptoms From Chemotherapy With a Low-Intensity, Low-Risk Cranial PEMF Device [NA]
FluxWear, INC is enrolling by invitation in a clinical study of a low-intensity cranial PEMF device to help manage chemotherapy-induced peri…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: The Effect of Personalized Exercise Interventions for the Prevention of Chemotherapy-induced Peripheral Neuropathy [NA]
The study investigates whether personalized exercise interventions can prevent chemotherapy-induced peripheral neuropathy, with recruitment …
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Association Between Work-Related Stress and Peripheral Neuropathic Pain in Female Breast Cancer Post CT
A clinical trial update describes an active-not-recruiting study examining the link between work-related stress and peripheral neuropathic p…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Tibial Nerve Elastography in Chemotherapy-Induced Neuropathic Pain
A clinical trial studying tibial nerve elastography for chemotherapy-induced peripheral neuropathy is currently not yet recruiting, sponsore…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Efficacy of External Application of Rosemary Oil in Patients With Chemotherapy-Induced Peripheral Neuropathy: a Feasibility Study [NA]
A completed feasibility study evaluated whether topical rosemary oil can reduce symptoms of chemotherapy-induced peripheral neuropathy.
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Combined Qigong and Acupressure for Improving Chemotherapy-induced Peripheral Neuropathy [NA]
This ClinicalTrials.gov update reports on a completed study assessing combining Qigong and Acupressure to improve chemotherapy-induced perip…
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy [NA]
The clinical trial evaluating Voxx socks for chemotherapy-induced peripheral neuropathy has completed and posted results in May 2025.
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients [Phase 2]
Phase 2 clinical trial update on prevention of paclitaxel-induced peripheral neuropathy in breast cancer patients; the study status is compl…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer [NA]
This clinical trial is evaluating transcutaneous electrical nerve stimulation for chemotherapy-induced peripheral neuropathy in patients wit…
-
CLINICAL_TRIALS other · 2025-04-23Clinical Trial Update: Effectiveness Assessment of Riluzole in the Prevention of Oxaliplatin-induced Peripheral Neuropathy. [Phase 2]
A Phase 2 trial evaluating riluzole to prevent oxaliplatin-induced peripheral neuropathy has been suspended.
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: Effect of Adding Electroacupuncture to Anti-cancer Therapy-induced Peripheral Neuropathy [NA]
A clinical trial evaluating whether electroacupuncture added to cancer therapy can alleviate chemotherapy-induced peripheral neuropathy. The…
-
CLINICAL_TRIALS research · 2025-04-13Clinical Trial Update: Wearable Focal Vibration for Chemotherapy-Induced Peripheral Neuropathy [NA]
A clinical trial update on a wearable focal vibration device being studied for chemotherapy-induced peripheral neuropathy, sponsored by the …
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Neuropathy. [Phase 2]
A Phase 2 clinical trial is evaluating scrambler therapy in combination with duloxetine-based usual care versus duloxetine-based usual care …
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Acupuncture Treatment of Chemotherapy-Induced Peripheral Neuropathy in Women [NA]
This clinical trial update reports termination of a study evaluating acupuncture for chemotherapy-induced peripheral neuropathy in women wit…
-
CLINICAL_TRIALS withdrawal · 2025-04-06Clinical Trial Update: Internet-delivered Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN) [NA]
A clinical trial evaluating internet-delivered management of chemotherapy-induced peripheral neuropathy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Study to Investigate the Chemotherapy-Induced Peripheral Neuropathy (CIPN) Onset-Suppressing Effect and Safety of ONO-2910 in Patients With Breast Cancer Receiving Weekly Paclitaxel [Phase 2]
Phase 2 study evaluating ONO-2910 for suppressing the onset of chemotherapy-induced peripheral neuropathy in breast cancer patients receivin…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Trimetazidine Efficacy in Attenuating Paclitaxel-Induced Peripheral Neuropathy [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluated trimetazidine for reducing paclitaxel-induced peripheral neuropathy in chemotherapy patients.
-
CLINICAL_TRIALS trial_result · 2025-03-27Clinical Trial Update: Methadone to Treat Painful Chemotherapy Induced Peripheral Neuropathy [Phase 2, Phase 3]
Clinical trial evaluating methadone for painful chemotherapy-induced peripheral neuropathy. The study is in Phase 2/Phase 3 and currently re…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: AK135 in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN) [Phase 1]
Phase 1 clinical trial update for AK135 in chemotherapy-induced peripheral neuropathy shows the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle Outcomes
A recruiting clinical trial investigating paclitaxel-induced polyneuropathy in breast cancer patients, focusing on early detection, risk fac…